Top Cheap Stocks To Invest In Right Now

AMSTERDAM (AP) -- European Central Bank head Mario Draghi said Monday that while the bank had averted financial "panic" in the euro union, it was still up to politicians to solve the region's core problems of strengthening the banking system and improving long-term growth.

The head of Europe's monetary authority said in a speech delivered in Amsterdam that the central bank had already warded off "fire sales" by investors through emergency measures. Those included launching �� trillion ($1.3 trillion) in cheap, three-year loans to banks to steady their finances and helping lower the borrowing costs of indebted countries by offering to buy government bonds on the open market.

Nonetheless, the economy of the 17 European Union countries that use the euro is mired in recession and is suffering from record unemployment. Meanwhile, borrowing conditions across the eurozone are fragmented: Companies in the indebted countries are paying more to borrow due to troubled government and bank finances than their more financially stable neighbors.

Top Cheap Stocks To Invest In Right Now: Cowen Group Inc.(COWN)

Cowen Group, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides alternative investment management, investment banking, research, and sales and trading services for its clients. It manages separate client focused portfolio through its subsidiaries. Through its subsidiaries, the firm invests in equity and fixed income markets. It also invests in alternative investments markets through its subsidiaries. Cowen Group, Inc. was founded in 1994 and is based in New York, New York with additional offices in Boston, Massachusetts, Chicago, Illinois, Cleveland, Ohio, Dallas, Texas, and San Francisco, California.

Advisors' Opinion:

• [By Michael Brush]

  The name isn't as common as others here, but you might remember the boutique investment banking and stock research shop Cowen Group (COWN). It helped hatch many of the midsize, high-growth tech and health-care companies during the late 1990s boom. Cowen itself went public in 2006, just in time to get trounced by an economic meltdown.

  Since the economy's upward turn, Cowen's stock hasn't rebounded as well as bigger rivals like Goldman Sachs, GS. But its time will come, insists Anton Schutz, the manager of the Burnham Financial Industries Fund (BMFIX), which owns the stock. "In a true bull market, Cowen is capable of earning over $1 a share," says Schutz. Since boutique investment banks carry price-to-earnings ratios at least in the low teens in good times, this stock could double or even triple from recent levels of $4 a share, Schutz reasons.

  Cowen recently purchased the brokerage LaBranche (LAB), whose presence on the Hong Kong stock exchange should help Cowen increase its investment banking business in China. "I expect this area to be of vital importance in growth for us," Cowen CEO and Wall Street veteran Peter Cohen said in the company's most recent conference call. LaBranche also gives Cowen much-needed electronic platforms supporting options and high frequency trading, says Sandler O'Neill analyst Devin Ryan, who has a $7 price target on the stock.

  Asset management arm Ramius, which offers hedge funds and mutual funds, should continue to perform well as the stock market and economy rebound. These trends will also support Cowen's U.S. brokerage and investment banking businesses. "The smaller brokers don't need that many crumbs to fall off the table to make some really good money," Ryan says.

  Meanwhile, Cowen's stock looks cheap, trading at about 70% of book value, compared with a 24% premium to book value at bigger rivals like Goldman Sachs (GS). That protects investors against downside, and also makes Cowen a possible buyout target.

Top Cheap Stocks To Invest In Right Now: UnitedHealth Group Incorporated(UNH)

UnitedHealth Group Incorporated provides healthcare services in the United States. Its Health Benefits segment offers consumer-oriented health benefit plans and services to national employers, public sector employers, mid-sized employers, small businesses, and individuals; and non-employer based insurance options for purchase by individuals. It also provides health and well-being services for individuals aged 50 and older; and for services dealing with chronic disease and other specialized issues for older individuals, as well as health plans for the beneficiaries of acute and long-term care Medicaid plans. This segment offers its services through a network of 730,000 physicians and other health care professionals, and 5,300 hospitals. Its OptumHealth segment provides health, financial, and ancillary services and products that assist consumers through personalized health management solutions; benefit administration, and clinical and network management; health-based financi al services; behavioral solutions; and specialty benefits, such as dental, vision, life, critical illness, short-term disability, and stop-loss product offerings. The company?s Ingenix segment offers database and data management services, software products, publications, consulting and actuarial services, business process outsourcing services, and pharmaceutical data consulting and research services. Its Prescription Solutions segment provides integrated pharmacy benefit management services comprising retail network pharmacy contracting and management, claims processing, mail order pharmacy services, specialty pharmacy, benefit design consultation, rebate contracting and management, drug utilization review, formulary management programs, disease therapy management, and adherence programs to employer groups, union trusts, managed care organizations, Medicare-contracted plans, Medicaid plans, and third party administrators. The company was founded in 1974 and is based in Minne tonka, Minnesota.

Advisors' Opinion:

• [By Victor Mora]

  UnitedHealth Group is a health and well-being company that provides essential healthcare services during a critical time in the United States. The stock has witnessed a promising move higher that has taken it to all-time high prices, where it may consolidate before coasting higher. Over the last four quarters, earnings and revenue numbers have been on the rise, but investors have not been too pleased with the company’s reports. Relative to its peers and sector, UnitedHealth Group has been a year-to-date performance leader. Look for UnitedHealth Group to OUTPERFORM.

• [By Jon C. Ogg]

  UnitedHealth Group Inc. (NYSE: UNH) is the newest of the DJIA components, now that Kraft Foods has split itself up. The health insurance giant closed out 2013 at $54.24, and that was well off the 52-week high, as its range in the past year was $49.82 to $60.75. Analysts believe that the stock will rise some 23.4% to $66.97 by the end of 2013. The insurer has a lower dividend than most DJIA stocks, at only about 1.6%, and its market value is close to $55 billion. UnitedHealth so far has recovered only about half of its losses from last summer.

• [By Ken Sweet]

  Shareholders of UnitedHealth (UNH) reaped the rewards this year from the managed care company's strong profits and upbeat guidance.

  UnitedHealth raised its full-year guidance in late April to $3.95 to $4.05 a share, well ahead of analysts' forecasts. The company also increased its quarterly dividend last month to 16.25 cents a share, from 12.5 cents a share.

  UnitedHealth's performance is also tied to what has been broad investor interest in healthcare stocks this year as a defensive play against what has been a recently downward-trending market.

• [By Victor Mora]

  UnitedHealth Group is a diversified healthcare company that is seeing increased attention as healthcare concerns take center stage. The stock has been steadily trending higher, and is now trading near all-time high prices. Over the last four quarters, earnings and revenue figures have been on the rise, but investors in the company expected a little more. Relative to its strong peers and sector, UnitedHealth Group has had an average year-to-date performance. Look for UnitedHealth Group to continue to OUTPERFORM.

Top 5 Clean Energy Stocks To Invest In 2014: CVS Corporation(CVS)

CVS Caremark Corporation operates as a pharmacy services company in the United States. The company?s Pharmacy Services segment provides a range of pharmacy benefit management services, including mail order pharmacy services, specialty pharmacy services, plan design and administration, formulary management, and claims processing; and drug benefits to eligible beneficiaries under the Federal Government?s Medicare Part D program. This segment primarily serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals. As of December 31, 2010, it operated 44 retail specialty pharmacy stores, 18 specialty mail order pharmacies, and 4 mail service pharmacies located in 25 states, Puerto Rico, and the District of Columbia. This segment operates business under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, CarePlus, RxAmerica, Accordant, and TheraCom names. The company?s Retail Pharmacy segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, seasonal merchandise, greeting cards, and convenience foods through its pharmacy retail stores and online, as well as offers film and photo finishing, and health care services. This segment operated 7,182 retail drugstores located in 41 states, Puerto Rico, and the District of Columbia; and 560 retail health care clinics in 26 states and the District of Columbia under the MinuteClinic name. It has a strategic alliance with Alere, L.L.C. for the management of disease management program offerings that cover chronic diseases, such as asthma, diabetes, congestive heart failure, and coronary artery disease. CVS Caremark Corporation was founded in 1892 and is based in Woonsocket, Rhode Island.

Advisors' Opinion:

• [By Holly LaFon] CVS/Caremark is the nation's premier integrated pharmacy services provider, combining one of the nation's leading pharmaceutical services companies with the country's largest pharmacy chain.
  
  Owens had a relatively small holding of 200,000 shares which he purchased in the third quarter of 2011 at about $36 per share. In the fourth quarter, he increased his holding by 50%, adding 100,000 shares at about $37 per share. CVS�� share price has actually increased more than 20% in the last year, and more than 21% in the fourth quarter alone.
  
  Record-setting third-quarter earnings results, announced Nov. 3, 2011, contributed to the rise. Net revenues increased 12.5% to a record $26.7 billion. Revenues in its Pharmacy Services segment rose 25.8% to $14.8 billion, due primarily with the addition of a previously unannounced, long-term contract with Aetna Inc., and its acquisition of the Medicare prescription drug business of Universal American Corp. in the second quarter of 2011.
  
  In the first nine months of 2011, the company also returned over $3 billion to shareholders in the form of dividends and share repurchases.
  
  CVS has been growing over the long term as well. Its revenue per share increased at a 10-year annual rate of 11.5%, and its free cash flow per share increased at a 10-year annual rate of 21.4%. GuruFocus rated CVS Caremark the business predictability rank of 4.5-star. Steven Romick did an extensive analysis of CVS here.
  
  Boston Scientific Corp. (BSX)
  
  Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices.
  
  Owens bought 9,200,000 shares of Boston Scientific Corp. at about $8.70 per share. In the next three quarters, he bought a total of 12,900,000 more shares at $8, $6.50 and $5.75 per share, respectively. He sold a total of 800,000 shares in the fourth quarter of 2010 and the first quarter of 2011 at about $7 per share. He then bought 3,300,000 shares at about $7 per share in the second q! uarter of 2011, 1,800,000 shares at about $6.50 in the third quarter, and 9,900,000 shares at about $5.50 in the fourth quarter.
  
  Boston Scientific�� revenue over the past decade has gone up and down, most recently decreasing to $7.8 billion in 2010,
• [By Victor Mora]

  CVS Caremark provides valuable health care and pharmacy products and services to many consumers in the United States. The stock has been on a powerful move higher but is now digesting gains from a recent run. Over the last four quarters, earnings and revenue figures have increased for the company, but investors seem to have had mixed feelings about the reports. Relative to its peers and sector, CVS Caremark has been an average performer year-to-date. Look for CVS Caremark to OUTPERFORM.

Top Cheap Stocks To Invest In Right Now: TranSwitch Corporation(TXCC)

Transwitch Corporation designs, develops, and supplies semiconductor and intellectual property solutions for voice, data, and video communications equipment. The company provides integrated multi-core network processor system-on-a-chip (SoC) and software solutions for fixed, 3G and 4G mobile, VoIP, and multimedia infrastructures. It offers converged network infrastructure products, including infrastructure VoIP processors comprising Entropia series of processors for wire-line and wireless carrier equipment; EoS/EoPDH mappers and framers for formats and data speeds in the access portion of the network; tributary switches that enable traffic to be switched or re-arranged; and carrier Ethernet solutions consisting of Ethernet controllers and switches, as well as circuit emulation and clock recovery devices. The company also provides FTTx protocol processors, such as mustang, a system-on-chip solution for EPON optical network unit equipment; COLT processor, a system-on-chip so lution for the optical line terminator equipment; and Diplomat-ONT product, an integrated SoC solution for GPON ONU applications, as well as access VoIP processors and access controllers. In addition, it offers broadband customer premises equipment, including multi-service communications processors comprising Atlanta processor, a multi-service SoC for customer premises equipment that supports toll-quality telephone voice, fax, and routing functionality; and HDMI, displayport, HDP, and Ethernet IP cores for consumer electronics, home network equipment, and industrial and automotive applications. The company serves public network systems OEMs, WAN and LAN equipment OEMs, Internet-oriented OEMs, and communications test and performance measurement equipment OEMs, as well as government, university, and private laboratories. It sells its products through direct sales force, independent distributors, and sales representatives. The company was founded in 1988 and is headquartered in Shelton, Connecticut.

Advisors' Opinion:

• [By Michael Brush]

  If you find yourself craving more high-definition video on your smartphone or tablet computer or if you've been checking out 3D televisions -- the next big trend -- you already know why TranSwitch (TXCC) stock should be a winner over the next few years.

  Once a techmania darling, trading at more than $500 a share, TranSwitch crashed and burned along with so many other Internet stocks. It has been all but left for dead since. Wall Street analysts are predicting the stock will actually have fallen to $2 a year from now, from recent levels of around $2.60, according to Thomson Reuters.

  What they're missing is that TranSwitch has revamped its chip offerings so they support high-definition video connections in TVs, PC and game monitors, smartphones, tablets and video cameras. This exposes the company to some big consumer trends. Another new product line supports gear that connects homes, offices and smartphones to the Internet.

  Those analysts and other investors don't put much faith in these new products. So why should you? Because the right kinds of insiders have been accumulating stock. Many of the new products are scheduled to hit the market over the next three months and generate meaningful sales by the fourth quarter. So now is the time to buy.

  Of course, we don't know for sure that TranSwitch's new products will catch on. But behind the scenes, they've been licensed by the likes of Intel (INTC), International Business Machines (IBM), Texas Instruments (TXN) and Analog Devices (ADI), Ted Chung, the TranSwitch vice president of global business development, tells me. That suggests TranSwitch may work its way into the Apple (AAPL) iGadget ecosystem, says Northland Capital Markets analyst Richard Shannon. That would be a game-changer for tiny TranSwitch, but the markets for its new products are so big that it probably can win even without such an advantage

Top Cheap Stocks To Invest In Right Now: Majesco Entertainment Company(COOL)

Majesco Entertainment Company develops and markets video game products primarily for family oriented mass-market consumers. The company publishes video games for various interactive entertainment hardware platforms, including Nintendo?s DS, DSi, and Wii; Sony?s PlayStation 3 and PlayStation Portable; Microsoft?s Xbox 360; and personal computers. It also publishes games for various digital platforms consisting of mobile platforms comprising iPhone, iPad, and iPod Touch, as well as online platforms, including Facebook. The company sells its products primarily to retail chains, specialty retail stores, video game rental outlets, and distributors. The company was founded in 1998 and is based in Edison, New Jersey.

Advisors' Opinion:

• [By Louis]

  Majesco Entertainment (NASDAQ: COOL) is an innovative provider of video games for the mass market, developing a wide range of titles for Sony’s PlayStation, Microsoft’s Xbox and Nintendo’s WII systems. On June 7, COOL announced that it had signed a contract with the NBA to begin development of an original video-game basketball franchise. The stock rose an impressive 32% over the next five trading days while the broader market sold off.

  However, the stock is down today after reporting weaker-than-expected second-quarter earnings last night, missing consensus earnings estimates by 2 cents. Majesco reported net revenues of $32.1 million for the second quarter ended April 30, 2011, compared with $10.9 million reported for the same period in the previous year. The company’s operating income for the second quarter was $5.3 million, compared with an operating loss of $1.6 million reported for the same period in the previous year. So treat this sell-off as a buying opportunity.